国产人妖视频一区二区破除_一区二区三区精品国产_婷婷在线视频国产综合_国产在线观看一区二区三区四区_国产亚洲综合一区二区在线_国产精品久久久久激情影院_99久久久国产精品免费牛牛四川_99re热这里只有精品视频_国产成人精品视频一区二区不卡

<bdo id="lgyom"><strong id="lgyom"><acronym id="lgyom"></acronym></strong></bdo>

<menu id="lgyom"><i id="lgyom"></i></menu>

<pre id="lgyom"></pre>

<bdo id="lgyom"><strong id="lgyom"><thead id="lgyom"></thead></strong></bdo>

Home > Category > Chiral Reagent > (η5-?2,?4-Cyclopentadien-?1-?yl)?[(1,?2,?3,?3a,?8a-?η)?-?(8aR)?-?1,?8-?dihydro-?8-?oxocyclopent[a]?inden-?1-?yl]?iron

(η5-?2,?4-Cyclopentadien-?1-?yl)?[(1,?2,?3,?3a,?8a-?η)?-?(8aR)?-?1,?8-?dihydro-?8-?oxocyclopent[a]?inden-?1-?yl]?iron

Daicel≥98%,98%e.e.

Catalog No：136661-100MG CAS No.：31989-10-3 MDLNo： Brand:Daicel purity：≥98%,98%e.e. 特性： Purpose:

Share

Size	Availability	Price(USD)
100MG	請咨詢	$1750.00

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	(η5-?2,?4-Cyclopentadien-?1-?yl)?[(1,?2,?3,?3a,?8a-?η)?-?(8aR)?-?1,?8-?dihydro-?8-?oxocyclopent[a]?inden-?1-?yl]?iron
CAS	31989-10-3
Formula	C₁₇H₁₂FeO

Security information

Related literature

Sorry, there is no relevant literature

Related

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole)

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole)

2409652-68-0 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1,1'-[(1S)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1S)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1R)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1R)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

(S)-2,2'-Bis(diisopropylphosphanyl)-1,1'-binaphthalene

(S)-2,2'-Bis(diisopropylphosphanyl)-1,1'-binaphthalene

History

(η5-?2,?4-Cyclopentadien-?1-?yl)?[(1,?2,?3,?3a,?8a-?η)?-?(8aR)?-?1,?8-?dihydro-?8-?oxocyclopent[a]?inden-?1-?yl]?iron

(η5-?2,?4-Cyclopentadien-?1-?yl)?[(1,?2,?3,?3a,?8a-?η)?-?(8aR)?-?1,?8-?dihydro-?8-?oxocyclopent[a]?inden-?1-?yl]?iron

31989-10-3 ≥98%,98%e.e.